Connell Consulting
Essential reading for the healthcare business
 
 
Remember me:
Skip Navigation LinksHealthInvestor article
Axis-Shield resists new Alere takeover attempt

UK-based diagnostics company Axis-Shield has urged shareholders to resist a fresh takeover attempt by US rival Alere.

In a statement today, Alere repeated its offer to Axis-Shield’s shareholders of 460 pence per share, which was formally made on 5 August. The offer, rejected by the Axis-Shield board, values the business at £230 million.

Alere announced today that it is lowering the threshold of its bid, which had been set at 90% of shareholder acceptance. The company said it now required more than 50% of voting rights, giving it the option of becoming a majority shareholder in Axis-Shield.

The US company also warned that if its offer were to lapse by a deadline of 10 October, “there is a strong possibility that Axis-Shield's share price would fall significantly below its current share price, particularly as no other potential bidder has announced its interest publicly”.

Alere said it was also looking at “alternative acquisitions, particularly in light of current valuations and market conditions”, and that it didn’t necessarily have to acquire Axis-Shield in order to achieve its “strategic objectives”.

In response, Axis-Shield’s board said it was “disappointed” that Alere had not taken notice of the “firm rebuttal” from shareholders to its offer, which it said was clear by the less than 1% level of acceptances that was disclosed in an Alere announcement on 16 September.

“The board has been more than willing to engage with Alere if Alere were to put a proposal to the board that fairly reflected the fundamental value of Axis-Shield. To date, no such proposal has been received from Alere,” said an Axis-Shield statement.

“The company has made excellent progress in the first half of the year and is on track to deliver for the second half of the year. The company believes that Alere is making a highly opportunistic offer in order to try and acquire Axis-Shield on the cheap.”

The 460 pence per share offer price represents a premium of 37% on the closing share price of 335 pence on 5 July 2011 – the last business day before Alere revealed it was considering an approach.
 

Posted on: 26/09/2011

Latest news stories

21/09/2017
Consumer demand for private healthcare has increased by 63% since 2013, according to new research.
21/09/2017
Andrew Shelton-Murray has taken on the post of interim chief executive of Swanton Care & Community following the firm’s recent acquisition by Apposite Capital.
20/09/2017
Nuffield Health and VitalityHealth have launched a joint venture that will provide large employers with a health and engagement solution for their workforces.
20/09/2017
August Equity has appointed former Nuffield Health deputy chief executive KP Doyle as chief executive of Active Assistance to lead a secondary buyout of the business, HealthInvestor UK understands.
20/09/2017
Private hospital group Spire Healthcare has paused its plans to build a £500 million private hospital in London, according to the Telegraph.


Civica


company profile: The Good Care Group

Managing director Belinda Berkeley tells Sarah Williams how The Good Care Group is evolving from responsive to preventative care, in the pursuit of excellence
Read more


HealthInvestor Events


private hospitals
As more international players close in on London, Sarah Williams takes a look at the investment case for the private hospitals springing up beyond the capital
Read more


Christie + Co

HealthInvestor Events


interview - Chai Patel

As he prepares to hand over his last chief executive role, one of the industry's most recognisable figures, Chai Patel, discusses his career with Ploy Radford
Read more


HealthInvestor App


delayed transfers of care

'Bed blocking' has increasingly dominated headlines, and the case for care homes to help has been repeatedly put forward. So, why has nothing been done? Ploy Radford investigates
Read more



HealthInvestor blog
Online healthcare providers need to be whiter than white or risk tarnishing the public image of private healthcare further

Click here to view the Editor's blog


UK prison demographics are shifting older in absolute terms and as a proportion of the prison population, find Clare Connell and Henry Hunt of Connell Consulting
Dr Sham Dholakia and Dr Michelle Tempest of Candesic argue that ‘London calling’ is so much more than a song by The Clash; it has become the speed dial signature tune to international medical markets
Managing director Belinda Berkeley tells Sarah Williams how The Good Care Group is evolving from responsive to preventative care, in the pursuit of excellence
‘Bed blocking’ has increasingly dominated headlines, and the case for care homes to help has been repeatedly put forward. So, why has nothing been done? Ploy Radford investigates
As he prepares to hand over his last chief executive role, one of the industry’s most recognisable figures, Chai Patel, discusses his career with Ploy Radford

Click here to search all feature articles